Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver disease-current evidence
Statistical analysis Events of reported pancreatitis and exposure (patient years) to either incretin-based drugs (GLP-1 receptor agonists or DPP-4 inhibitors) or non-incretin-based comparator drugs/placebo were compared using contingency table analysis, calculating the ORs, 95% CIs and p values for the comparison, using GraphPad Prism version 5.02 for Windows (GraphPad Software, San Diego, CA, USA
Pancreatic Hormones & Antidiabetic Drugs
While our products are gastrically stable, some reports indicate that taking them after a meal improves absorption
Wnt signaling promotes -catenin stabilization and nuclear translocation, causing the downstream inhibition of C/EBP and PPAR
Ascorbic acid incorporated with walnut green husk extract for preserving the postharvest quality of cold storage fresh walnut kernels